Fundz

Intel Capital And Khosla Ventures Lead $27M Investment In Siphox® Health To Transform Health Testing

PRIVATEJul 19, 2023

Amount Raised

$27 Million

Round Type

Venture

BurlingtonInformation TechnologyBiotechnology

Investors

Intel Capital Managing Director Srini AnanthLongevity Tech FundBob LeeBalaji SrinivasanPaul BuchheitVituityRsquaredMassachusetts Manufacturing Innovation InitiativeY CombinatorDuke Capital PartnersOverlap HoldingsLonge VCShorewind CapitalMetaplanetAlumni VenturesKortex VenturesKhosla VenturesIntel Capital

Description

SiPhox Health, the leader in building the next generation of lab-grade home health testing with silicon photonics, raised $27 million in funding including a $10M Seed financing and a $17M Series A round. The Series A round was led by Intel Capital with participation from Khosla Ventures, Kortex Ventures, Alumni Ventures, Metaplanet, Shorewind Capital, LongeVC, Overlap Holdings and Duke Capital Partners. The Seed funding was led by Khosla Ventures and Y Combinator with participation from Metaplanet, Massachusetts Manufacturing Innovation Initiative, Rsquared, Vituity, Paul Buchheit, Balaji Srinivasan, Bob Lee, and Longevity Tech Fund among others. Intel Capital managing director Srini Ananth will also join SiPhox Health’s board of directors to further accelerate the company’s growth.

Quick answer

SiPhox Inc. raised $27 Million in a funding round, dated July 19, 2023. Investors: Intel Capital Managing Director Srini Ananth, Longevity Tech Fund, Bob Lee, Balaji Srinivasan, Paul Buchheit, Vituity, Rsquared and Massachusetts Manufacturing Innovation Initiative. SiPhox Inc. is based in Burlington, Massachusetts, United States.

How much did SiPhox Inc. raise?
SiPhox Inc. raised $27 Million in a funding round on July 19, 2023.
Who invested in SiPhox Inc?
Intel Capital Managing Director Srini Ananth, Longevity Tech Fund, Bob Lee, Balaji Srinivasan, Paul Buchheit, Vituity, Rsquared and Massachusetts Manufacturing Innovation Initiative are named as investors in this round.
What does SiPhox Inc. do?
SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020.
Where is SiPhox Inc. based and how big is it?
SiPhox Inc. is based in Burlington, Massachusetts, United States.
Who are the decision-makers at SiPhox Inc?
Fundz holds 1 contact at SiPhox Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SiPhox Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Delcath Systems raised $35M (Funding Round) on September 1, 2023.
  • Cardio Flow, Inc. raised $100K (Seed) on September 1, 2023.
  • Innovac Therapeutics raised $18M (Funding Round) on September 1, 2023.
  • Measurlabs raised $2.7M (Seed) on September 1, 2023.
  • Just Egg raised an undisclosed amount (Funding Round) on September 1, 2023.
  • March Biosciences raised $9K (Pre-Seed) on September 1, 2023.

Who to call at SiPhox Inc., and when

A new round usually means SiPhox Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SiPhox Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SiPhox Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SiPhox Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SiPhox Inc.

Location

111 TERRACE HALL AVE.

Burlington, Massachusetts, United States

About

SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020. SiPhox’s mission is to build a next-generation biosensing platform that provides the power of several large laboratory instruments in a handheld device that accepts disposable cartridges. Each cartridge can multiplex many biomarkers on a single $0.50 silicon photonic chip and provides highly sensitive readout of immunoassays and RNA/DNA. The SiPhox team has extensive experience translating cutting-edge optical chip technology into mass produced products used all over the world, and is bringing the same proven approach to the next frontier for integrated photonics: biology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SiPhox Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael D., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SiPhox Inc.'s next move

See what Strategic adds

SiPhox Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.